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It is generally believed that successful robot users have dedicated
centralized robotic groups. While such a generalization holds some
merit historically, the availability ofnewer more user-friendly robots
and workstations in recentyears and a more computer-literate work
force today is changing the way that automation can be managed.
Decentralization recognizes robots and workstations as additional
toolsfor all analysis, nol a selectfew. Such an approach initiates
involvement and education ofmore staff with respect to automation.
This further ushers the development of automated methods instead
ofthe automation ofmanually-developed methods. Decentralization
also provides local control of resources to address the priorities of
a specijicfunctional group within the department. Both a vision of
hefuture, as well as a look a the past, should be considered when
determining how to manage robotic and other means ofautomation.
This paper discusses decentralized management of robots as
currently applied and envisioned in a large pharmaceutical
analytical R & D department.
Introduction
A pharmaceutical analytical R&D department is
responsible for the development and application of test
procedures in order to evaluate the stability and quality
specifications tbr the drug product and its components.
A pharmaceutical analytical R&D department will
usually function as a ’QC laboratory’ for supplies used
during preclinical and clinical investigations. This
development stage of the novel drug substance occurs
during a six to eight year period for any one project.
These activities culminate in the submission of a
regulatory package of intbrmation that supports the
commercialization of the product. The environment is
dynamic in that project priorities and projects themselves
can change on a fairly frequent basis. Only about one in
12 compounds that are recommended for development
ever become successful commercial products. Nine of the
12 will never become products because they are clinical
tMlures or are economically unpromising. Two of the 12
will be market failures, and only one of the 12 will be a
commercial success [1]. It is rare to have projects in a
pharmaceutical analytical R & D department that have
large routine sample loads on a daily or even a weekly
basis tbr any one project. Certainly nothing as great as
what a Q.C laboratory could experience with 100 to 200
or more batches per year for a single product. However,
large numbers of commercial batches only occur for one
in three projects that are envisioned as being a market
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success. Thus, justifying an R & D investment in robotics
based on a potential future return in QC only has a one
in three chance ofcoming to fruition. In the Physical and
Analytical Chemisty R &D department at Schering-
Plough, it is the summation of clinical supply testing and
stability samples that can provide a potential work load
for which the investment in automation can be justified.
However, the investment must be controlled, and the
centralization of the automation effort may not be the
best way to support the dynamic nature of the task in a
department with diverse automation needs. Furthermore,
it should be remembered that gains in productivity are
not the only advantages to automation. Improvements in
quality of data as well as employee job satisfaction can
also be realized [2, 3-].
During a presentation at ISLAR 91, Tomlinson I-3] said:
’Also noteworthy from our compilation of information
was that the successful robot users eventually evolved
dedicated, centralized robotics groups that develop the
systems to be used as turnkey instruments by staff that
are inexperienced in automation’. Such a conclusion
appears to be appropriate for work functions that have
large routine sample loads. However, the process of
automating the analytical laboratory has not yet been
completed. Therefore, the optimum way in which to
manage robotics may still be evolving, and the concept
that centralization is best may only be true for this
particular time in the evolutionary cycle or at least only
true for some types of laboratories. Interestingly, during
ISLAR 84 it was envisioned that: ’Automation specialists
are emerging as a new function in the laboratory.
This evolution is similar to that which created the
need for chemical engineers and/more recently, computer
specialists. In the future; as this technology becomes
widely used, these specialists will disperse back into the
operating organization’ [4].
During ISLAR 85 Francis Zenie i-5] also noted that: ’The
laboratory of the future will be open with islands devoted
to integrated systems. Laboratories will be more
decentralized with clearer responsibility for final results
including precision, cost and turn around time’.
So, where are we in the evolutionary process oflaboratory
automation, especially with respect to implementation of
robotics?
History
The Physical and Analytical Chemistry Department
within Schering-Plough Research Institute has been
involved with robotics since 1984. The first Zymark robot
was purchased without a specific project in mind. Since
that time, it has been noted that under such circumstance’s
the potential for success is limited [6, 7]. However, the
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concept was to evaluate the feasibility of using robots in
the laboratories. Also, within any organization, one
would expect that the R & D staff should be evaluating
new technologies and will need to invest time in learning.
The individual responsible for the laboratory computer
system was given the additional responsibility for
robotics. Time had to be split between the two
responsibilities and only about 40 of the individual’s
time was spent on robotics. Several small projects were
completed but without a large payoff. This was a result
of the changing environment in R & D that can make
what was needed yesterday no longer important
tomorrow, as well as the large investment of time (three
to six months) that was needed to develop useful robotic
systems in the 1980s. The major benefit gained from those
early days of involvement with robotics was the
knowledge acquired by the staff.
Within the Analytical R &D department there are
several functional groups such as Dissolution Analysis,
Dosage Formulation Analysis, Inhalation Product
Analysis and Computer Systems Support. The beginning
of decentralized automation management occurred
during the late 1980s when the Dissolution Analysis
section became the first group outside of the computer
systems support area to be involved with their own robot
applications even though there was still an aspect of
central control. By 1989, two staff members in the
Dissolution Analysis area were involved with dissolution
robotics and were directed by the manager of that area.
The manager of the Laboratory Automation Group was
directing the activity ofone staffmember for development
of a robot for testing aerosol as well as a staff member of
the Dosage Formulation Analysis areas. Such an
arrangement led to success, some disappointment and a
new look at how the Institute manages robotics.
The development of the custom aerosol robot required
about two years at a total resource (labour and capital
expenditures) cost of $700000. Since 1989, this system
and an additional clone of this system initiated in 1993
have resulted in a cost savings in our QC laboratories of
about $350 000 a year per robot. Thus, we have certainly
had success with our investment in robotics; however, in
1990 it was recognized that it was time to re-evaluate how
the automation resources were managed. Those involved
with computer support could no longer afford to spend
time on robotics. Dilution of one of these individual’s
efforts had probably doubled the elapsed time required
for implementation of the aerosol robot. Direction of staff
in other groups by the Computer System Support
manager to develop robotic systems was also being met
with resistance by the project manager. So it was time for
a complete change.
Decentralization
Computer System Support, Dissolution and Dosage
Formulation Analysis became independently responsible
for managing their resources for automation. The Dosage
Formulation Analysis group began its independent
robotic automation efforts by evaluating the advantages
of PyTechnology. It was recognized that the Zymate
robots of the 80s would not meet current needs, but
that a System V robot with PyTechnology and in
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house programming would provide the type of robot
systems that could be quickly adapted to the Institute’s
changing requirements. PyTechnology provided many
preprogrammed sections, and additional PySection
software routines have been self-programmed and are now
available for use with similar projects. Today, the
potential application of robotics to every new project is
evaluated. Since the decision to automate rests with the
same associate director who is involved with the broad
R & D scope of the project’s management, information
pertaining to the potential success and other details of the
project are directly available. There is no need for
meetings between a centralized automation group and
the end user of the automation. Thus, it is possible to
react to project changes and priorities in a much more
efficient manner. Given a new assignment, a fully
documented and validated robot system for assay sample
preparation can be implemented within three weeks.
Computer System Support was divorced from robotics
and was focused on the maintenance and further
development of the Institute’s LAS and LIM systems.
This focus has enabled them to expand their services
throughout the department and to support the develop-
ment of a new and expanded LAS/LIM system.
The dissolution group, with knowledge gained from
previous experience, was able to more accurately assess
their own needs for automation. They have determined
that it is more cost effective to use in-house developed
automated sampler/analysis systems for extended release
dosage forms for which the dissolution runs last from 12
to 24 hours on a set of samples. However, the advantages
of a robotic dissolution system are observed when there
is the need to test numerous immediate tablet dosage
forms. The staff in the dissolution group can self assess
which automation technique to apply for options available
within their own control, as well as evaluate new systems
and determine as to whether their purchase is justified.
The resource to program and troubleshoot their systems
is available within the group, and each year additional
staff become more knowledgeable as to the workings of
each available system.
During the past year, Inhalation Product Testing has
decided to implement the use of robots to aid in analysing
numerous samples that will be generated by projects that
are responding to the elimination of fluorocarbon
propellants. These robots required some modification of
the previously developed aerosol robots, and the new
custom systems have been developed in conjunction with
Zymark. Again, decentralization has allowed them to
directly buy-in to selecting the form of automation and
guiding its development so that they can meet the
particular project goals.
How robots are managed is as much a function of
the culture of the organization as it is specific to
management ofautomation or, more specifically, robotics.
Decentralization provides ownership; more members of
the analytical staff are directly involved and not just
’looking through the window’ at the automation efforts.
They now have the ultimate responsibility for the
successful application of the automation resources they
have chosen. The willingness ofemployees to make it work
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Decentralization encourages participation by all members
of the staff. There is no perceived class system in which
only an 61ite few are involved with robotic development.
Decentralization can therefore improve employee morale.
Staff members see participation in automation as a
career development opportunity that can also reduce the
routine nature of some of their work.
Communication concerning the project being automated
is also improved. Development of the robotic system
is within direct control of the department manager
responsible for the project. The analyst developing
the analytical procedures for the project is also in-
volved directly with the robotic system development
simultaneously. The robotic system is more likely to meet
the end users needs than one centrally developed by
others.
Decentralization provides a broad base of expertise in
automation. The loss of one or even two key individuals
will not cripple existing or future projects.
Decentralization: the future
Schering-Plough has now assembled a critical mass of
equipment and have trained a sufficient number of our
analytical staff to not only run the robots but to program
and execute the necessary system validations.
To be truly successful in fully automating the Institute’s
laboratories, especially in Analytical R & D, the auto-
mation techniques must be in the hands of almost
everyone, not just a select fiw. Analytical methods should
be developed with automation instead of automation of
manually developed methods. How much time and money
is now spent in showing equivalence of the robot method
to the initially developed manual method? Why not
validate the robot system first? Such an approach may be
met with some regulatory resistance, since the the FDA
has to validate the procedures. However, this is part of
the challenge: whenever one is promoting change in how
one operates, one must recognize there will be resistance.
Automation is going to reduce the amount ofroutine work
in laboratories. Therefbre, the need for employees who
are only capable of’performing routine tasks will diminish.
Halloran and Rulon have noted that those involved in
developing robotic applications need to have skills
associated with programming and engineering as well as
chemistry [7, 8]. The talents and abilities of almost all
laboratory employees will need to reflect these needs.
Chemists graduating f?om college in the 90s are certainly
more computer literate that those of" the 70s. Training
can also be an answer to providing staff members with
the proper tools. Some may look at training as a unique
additional cost of automation. Training is an additional
cost, but it is a cost associated with the application of any
useful technology. HPLC was introduced into most
pharmaceutical laboratories about 20 years ago and yet
today many of us still spend money on HPLC courses for
some ofour employees each year. These costs never end.
Vendors of laboratory automation will also need to
continue to strive to develop products that reduce the
learning curve and its time course. Simpler programming
languages, efficiency in establishing new programs and the
development of focused yet useful workstations are
essential to reducing the barriers to decentralization.
Conclusion
There is no single best way to manage laboratory
automation. A manager’s own knowledge, the experience
of others, the nature of his/her projects and an
understanding of her/his own corporate culture are
major factors which will influence the way in which
he/she determines to manage the automation function.
Technology and people are both constantly changing and
require that we periodically reconsider how we manage
our resources for optimum performance. Managers should
consider their own alternatives and make their own
decisions and not merely follow the successful path of
others whose projects, culture, and staff may be
significantly different.
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